Home Applications 761274 Application 761274
Type BLA
Sponsor BIOCON BIOLOGICS INC Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761274 Yesafili aflibercept-jbvf 351(k) Interchangeable Rx 2026-06-01
Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 YESAFILI AFLIBERCEPT-JBVF INJECTABLE;INJECTION 2MG(0.05ML,40MG/ML) No No
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 ยท 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join YESAFILI AFLIBERCEPT-JBVF Biocon Biologics Inc. 7d69a7b0-9511-c030-3b85-13b23f9d2980 2026-07-28 Warnings, Adverse reactions Exact identifier application number: BLA761274
Documents# Document, Submission type, Date table Document Submission type Date 84777 SUPPL 2026-01-20 84754 SUPPL 2026-01-15 80478 ORIG 2024-12-03 78520 ORIG 2024-05-20 78512 ORIG 2024-05-20